ArticleHIV medicine2022
Impact of coronavirus disease (COVID-19) on HIV testing and care provision across four continents.
Article in HIV medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
76 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Evaluating the impact of COVID-19 on the HIV care continuum across global income levels: a mixed-methods systematic review.AIDS research and therapy · 2025Pooled it
- Impact of COVID-19 on Utilization of Healthcare Services Among People Living with HIV (PLHIV): A Systematic Review.Medicina (Kaunas, Lithuania) · 2025Pooled it
- HIV Testing Disruptions and Service Adaptations During the COVID-19 Pandemic: A Systematic Literature Review.AIDS and behavior · 2024Pooled it
- Cost-effectiveness analysis of a community-based model for delivery of antiretroviral therapy to people with clinically stable HIV in Cambodia.Journal of the International AIDS Society · 2025Trial
- Increased prevalence of depression and anxiety among adults initiating antiretroviral therapy during the COVID-19 pandemic in Shinyanga region, Tanzania.AIDS research and therapy · 2023Trial
- Effect of COVID-19 on Late HIV Diagnosis Rates by Race/Ethnicity in Ending the HIV Epidemic Priority Jurisdictions in the United States.Journal of acquired immune deficiency syndromes (1999) · 2026Article
- From HIV testing to ART initiation under fire: joinpoint regression analysis of regional disparities during the full-scale war against Ukraine.Conflict and health · 2026Article
- Racial, ethnic, and regional disparities in HIV testing during the COVID-19 pandemic in the USA: a nationwide, retrospective, observational study using National Clinical Cohort Collaborative data.The lancet. HIV · 2026Observational
- Integrating HIV services in an era of global change.Journal of the International AIDS Society · 2026Article
- The Future of Newly Diagnosed HIV Cases in Iran Through 2030: A Mixed-Methods Trend Impact Analysis.HIV/AIDS (Auckland, N.Z.) · 2026Article
- Implementing voluntary counselling and testing services among university students in Mozambique: a mixed methods process evaluation.Frontiers in public health · 2026Article
- Challenges in HIV care at a tertiary hospital repurposed for COVID-19: an observational study (2019-2022).BMC infectious diseases · 2025Observational
- Impact of the COVID-19 pandemic on regional and national uptake of HIV testing services in Sierra Leone: a descriptive analysis.BMC public health · 2025Article
- Assessing the impact of COVID-19 on HIV and hepatitis B testing in Western Iran: insights from an interrupted time series analysis.BMC public health · 2025Article
- Evaluating the Effects of the COVID-19 Pandemic on HIV Testing, Enrollment, ART Use and Mortality in Suriname Using Interrupted Time Series Analysis.AIDS and behavior · 2025Article
- Variability in Human Immunodeficiency Virus infection screening: impact of the COVID-19 pandemic.Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2025Observational
- COVID-19 Pandemic's Impact on HIV and AIDS Case Reporting in Peru: A Time Series Analysis of Surveillance Data (1983-2023).AIDS and behavior · 2025Article
- Evaluation of the virtual care experience for persons in prospective cohorts with HIV during the COVID pandemic.PLOS digital health · 2025Article
- Outpatient Testing for HIV in Italy, 2018-2023-Preliminary Data.Microorganisms · 2025Article
- Are people with HIV at advanced disease stages being left behind? A global survey.HIV medicine · 2025Article
16 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe coronavirus disease (COVID-19) pandemic has been associated with severe disruptions in health care services, and nonpharmacological measures such as social distancing also have an impact on access to screening tests and on the long-term care of patients with chronic conditions globally. We aimed to describe the impact of the COVID-19 pandemic on HIV testing and treatment and to describe strategies employed to mitigate the impact of COVID-19 on HIV care.
methodsIn this retrospective cohort study, we used secondary data from the AIDS Healthcare Foundation (AHF) Global Quality Program from 44 countries in four continents (Asia, Latin America and the Caribbean, Europe and Africa), and compared information on HIV testing, percentage of positive results, number of in-person appointments, and number of new enrolments in HIV care from 1 January 2020 to 31 August 2020 with the equivalent period in 2019.
resultsDespite marked inter-country heterogeneities, we found that COVID-19 was associated with a significant reduction in HIV testing, an increase in the percentage of positive tests, a reduction in the number of in-person consultations and a reduction in the number of new enrolments in care, despite the implementation of several mitigation strategies. The impact of COVID-19 differed across continents and key populations.
conclusionsOur findings suggest that, in the years to come, health care services must be prepared to respond to the impact of COVID-19 on HIV testing and care. Providers and facilities should build on the lessons learned so far to further improve mitigation strategies and establish care priorities for both the pandemic and the post-pandemic periods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.